Bayer and biotech Onyx Pharmaceuticals announced a devastatingly disappointing result for their cancer pill Nexavar: They stopped a study of the drug in non-small cell lung cancer early because there was no chance it would reach its main goal of proving Nexavar extends patients' lives in that disease.
Companies like iDirect are promoting an alternative - small-cell technology, which allows mobile operators to backhaul data from sites, no larger than the average satellite dish.